Max S Topp

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Venues

The New England journal of medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Michael L Wang, Javier L Muñoz, Andre H Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn, Peter A McSweeney, David Bernard Miklos, John M Pagel, Marie José Kersten, Krimo Bouabdallah, Rashmi Khanal, Max S Topp, Houot Roch, Amer Beitinjaneh, Weimin Peng, Xiang Fang, Rhine R Shen, Rubina Siddiqi, Ioana Kloos, Patrick M Reagan
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Max S Topp, Anthony S Stein, Nicola Gökbuget, Heinz-August Horst, Nicolas Boissel, Giovanni Martinelli, Hagop M Kantarjian, Monika Brüggemann, Yuqi Chen, Gerhard Zugmaier
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis. Cancer medicine 10 (8) (2021)
Michael L Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn, Peter A McSweeney, David B Miklos, John M Pagel, Marie-Jose Kersten, Noel Milpied, Henry Fung, Max S Topp, Roch Houot, Amer Beitinjaneh, Weimin Peng, Lianqing Zheng, John M Rossi, Rajul K Jain, Arati V Rao, Patrick M Reagan
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. The New England journal of medicine 382 (14) (2020)

Max S Topp.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Max S Topp